Privacy issues in personalized medicine

Laszlo T. Vaszar, Mildred K. Cho, Thomas A. Raffin

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Pharmacogenomics is the emerging study of why individuals respond differently to drugs. It aims to replace the current 'one size fits all' therapeutic approach with 'personalized medicine' that will use pharmacogenomic tests to predict drug response. In a simple conceptualization, these tests challenge privacy as a result of two factors: how comprehensive is the test and how is the access to samples or digital information controlled. Point-of-care tests are likely to be limited in scope, fit seamlessly into medical records and do not raise qualitatively new ethical and privacy challenges. In order to define practically relevant pharmacogenomic predictive patterns however, large-scale clinical trials and research on human specimens will be required, resulting in large databases of genomic information. The genomic scans' magnitude, stability, implications to kin and ease of dissemination together represent a qualitatively different challenge compared to traditional, self-limited and often temporally transient medical information.

Original languageEnglish (US)
Pages (from-to)107-112
Number of pages6
Issue number2
StatePublished - Mar 1 2003


  • Biobanks
  • Bioethics
  • Bioinformatics
  • Confidentiality
  • Genome
  • Informed consent
  • Pharmacogenetics
  • Pharmacogenomics
  • Privacy

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology


Dive into the research topics of 'Privacy issues in personalized medicine'. Together they form a unique fingerprint.

Cite this